INNOVATIONMADE BY ZEISS
innovationMADE BY ZEISS
Medical Technology made by ZEISS
News
-
May 15, 2018
Carl Zeiss Meditec increased revenue in the first six months of 2017/18 by 4.5 percent
-
Apr 14, 2018
ZEISS presents diagnostic and surgical advancements at ASCRS
-
Feb 28, 2018
Dedicated training center for ophthalmologists inaugurated in Asunción
-
Feb 12, 2018
Carl Zeiss Meditec AG starts new fiscal year 2017/18 with solid revenue growth
Carl Zeiss Meditec AG
Visit our corporate website for further information
Carl Zeiss Meditec AG is the parent company of the Carl Zeiss Meditec Group which also includes other subsidiaries. The Group is the focus for most of the medical technology business group's activity within the ZEISS organisation. The company is listed on TecDAX of the German stock exchange.
Find out more on our coporate website.
Carl Zeiss Meditec AG Website
Investor Relations
Medical Disciplines
Ophthalmology
Diagnosis and treatment of eye diseases, including implants and consumables.
Gynecology
Diagnostic microscopes and solutions for digital visualization for gynecological applications.
Intraoperative Radiation Therapy (IORT)
Targeted intraoperative radiation therapy for cancer treatments of different tumor diseases.
Solutions for Ophthalmology and Microsurgery
ZEISS is one of the world’s leading suppliers of medical devices in the field of medical technology. It supplies innovative technologies and application-oriented solutions for ophthalmology and microsurgery designed to help doctors improve the quality of life of their patients.
ZEISS provides complete packages of solutions for diagnosis and devices for optical coherence tomography (OCT), perimetry, optical biometry and slit lamps. For the treatment of eye diseases ZEISS also offers not only ophthalmologic surgical microscopes, but also implants (intraocular lenses | IOLs) and consumables like ophthalmic viscosurgical devices (OVDs).
Within the field of microsurgery ZEISS creates innovative visualization solutions, especially surgical microscopes for minimally invasive surgeries. The medical technology portfolio is rounded off by promising, future-oriented technologies such as intraoperative radiotherapy.
Most of ZEISS’s medical technology activities are combined into Carl Zeiss Meditec AG, which is listed on TecDax of the German stock exchange. For more information, please click here.
Contact Us
